66863-43-2

Basic information

• Product Name: BOC-L-1,2,3,4-TETRAHYDRONORHARMAN-3-CARBOXYLIC ACID
• Synonyms: BOC-THNH(3)-OH;BOC-TPI-OH;BOC-L-TRYPTOLINE-3-CARBOXYLIC ACID;BOC-L-TPI;BOC-L-TPI-OH;BOC-L-1,2,3,4-TETRAHYDRO-9H-PYRIDO[3,4-B]INDOLE-3-CARBOXYLIC ACID;BOC-L-1,2,3,4-TETRAHYDRONORHARMAN-3-CARBOXYLIC ACID;RARECHEM BK PT 0089
• CAS NO: 66863-43-2
• Molecular Formula: C₁₇H₂₀N₂O₄
• Molecular Weight: 316.35
• Product Categories: Phenylalanine analogs and other aromatic alpha amino acids;Amino Acid Derivatives;Others;Peptide Synthesis;Unnatural Amino Acid Derivatives
• Mol File: 66863-43-2.mol

Chemical Properties

• Melting Point: 286-291 °C
• Boiling Point: 525.6oC at 760 mmHg
• Flash Point: 271.7oC
• Appearance: /
• Density: 1.322±0.06 g/cm3(Predicted)
• Vapor Pressure: 7.12E-12mmHg at 25°C
• Storage Temp.: 0-6°C
• PKA: 3.98±0.20(Predicted)
• BRN: 691288
• CAS DataBase Reference: BOC-L-1,2,3,4-TETRAHYDRONORHARMAN-3-CARBOXYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: BOC-L-1,2,3,4-TETRAHYDRONORHARMAN-3-CARBOXYLIC ACID(66863-43-2)
• EPA Substance Registry System: BOC-L-1,2,3,4-TETRAHYDRONORHARMAN-3-CARBOXYLIC ACID(66863-43-2)

Safety Data

• Hazard Codes: Xi
• Safety Statements: 24/25
• HazardClass: IRRITANT
• Hazardous Substances Data: 66863-43-2(Hazardous Substances Data)

Usage

InChI:InChI=1/C17H20N2O4/c1-17(2,3)23-16(22)19-9-13-11(8-14(19)15(20)21)10-6-4-5-7-12(10)18-13/h4-7,14,18H,8-9H2,1-3H3,(H,20,21)/p-1/t14-/m0/s1

Upstream product

• 1070-19-5 N-(tert-butyloxycarbonyl) azide 
• 42438-90-4 3-carboxy-1,2,3,4-tetrahydro-2-carboline 
• 24424-99-5 di-tert-butyl dicarbonate 
• 73-22-3 L-Tryptophan 
• 191279-37-5 (3S)-1-methyl-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid 
• 50-00-0 formaldehyd 
• 153-94-6 D-tryptophan 

Downstream Products

• 437652-99-8 3S-2-Boc-1,2,3,4-tetrahydro-β-carboline-3-carboxyl-Arg(Tos)-Gly-Asp(OcHex)-ValOBzl 
• 437653-00-4 3S-2-Boc-1,2,3,4-tetrahydro-β-carboline-3-carboxyl-Arg(Tos)-Gly-Asp(OcHex)-PheOBzl 
• 479218-83-2 3S-(2-Boc)-1,2,3,4-tetrahydro-β-carboline-3-carboxyl-Gly-Arg(Tos)-Pro-Ala-Lys(ClZ)-OBzl 
• 479218-79-6 3S-(2-Boc)-1,2,3,4-tetrahydro-β-carboline-3-carboxyl-Ala-Arg(Tos)-Pro-Ala-Lys(ClZ)-OBzl 
• 479218-81-0 3S-(2-Boc)-1,2,3,4-tetrahydro-β-carboline-3-carboxyl-Gln-Arg(Tos)-Pro-Ala-Lys(ClZ)-OBzl 
• 900865-85-2 N-((3S)-2-N-Boc-1,2,3,4-tetrahydro-9H-β-carboline-3-carboxyl)-L-(Z)lysine methyl ester 
• 900865-72-7 (S)-tert-butyl 3-((S)-1-methoxy-1-oxo-3-phenylpropan-2-ylcarbamoyl)-3,4-dihydro-1H-pyrido[3,4-b]indole-2(9H)-carboxylate 
• 900865-76-1 (S)-tert-butyl 3-((S)-3-(4-hydroxyphenyl)-1-methoxy-1-oxopropan-2-ylcarbamoyl)-3,4-dihydro-1H-pyrido[3,4-b]indole-2(9H)-carboxylate 
• 945650-40-8 N-[(3S)-N-Boc-1,2,3,4-tetrahydro-β-carboline-3-carboxyl]-L-alanine benzyl ester 
• 945650-54-4 N-[(3S)-N-Boc-1,2,3,4-tetrahydro-β-carboline-3-carboxyl]glycine benzyl ester 
• 900866-05-9 N-[(3S)-1,2,3,4-tetrahydro-β-carboline-3-carbonyl]-L-phenylalanine 
• 900866-09-3 N-[(3S)-1,2,3,4-tetrahydro-β-carboline-3-carbonyl]-L-tyrosine 
• 900865-88-5 N-((3S)-2-N-Boc-1,2,3,4-tetrahydro-9H-β-carboline-3-carboxyl)-L-phenylalanine 

Relevant articles and documents

Hexacyclic piperazinedione compound and preparation, biological activity and application thereof

The invention discloses a hexacyclic piperazinedione compound as shown in the following formula: tetrahydro-beta-carboline [3: 4] piperazine-2, 5-diketopiperidine [4: 5] imidazole. The invention discloses a preparation method and application thereof. The compound not only has an anti-tumor proliferation effect, but also can inhibit migration and invasion of tumor cells, and also has an in-vivo anti-metastasis effect.

Glucosamine modified pentacyclic piperazine diketone and preparation and application thereof (by machine translation)

Aminoglucose-modified pentacyclic piperazinedione, and preparation and application thereofCH in the following formula is disclosed. 2 CO- Aminoglucose-modified pentacyclic piperazinedione The invention discloses a synthetic method thereof, disc

Carboline ruthenium complex as well as preparation method and application thereof

The invention provides a carboline ruthenium complex as well as a preparation method and application thereof, and belongs to the technical field of biological medicines. The series of carboline ruthenium complexes provided by the invention not only can in

Indole-TEMPO conjugates alleviate ischemia-reperfusion injury via attenuation of oxidative stress and preservation of mitochondrial function

Mitochondrial oxidative damage contributes to a wide range of pathologies including ischemia/reperfusion injury. Accordingly, protecting mitochondria from oxidative damage should possess therapeutic relevance. In the present study, we have designed and synthesized a series of novel indole-TEMPO conjugates that manifested good anti-inflammatory properties in a murine model of xylene-induced ear edema. We have demonstrated that these compounds can protect cells from simulated ischemia/reperfusion (s-I/R)-induced reactive oxygen species (ROS) overproduction and mitochondrial dysfunction. Furthermore, we have demonstrated that indole-TEMPO conjugates can attenuate organ damage induced in rodents via intestinal I/R injury. We therefore propose that the pharmacological profile and mechanism of action of these indole-TEMPO conjugates involve convergent roles, including the ability to decrease free radical production via lipid peroxidation which couples to an associated decrease in ROS-mediated activation of the inflammatory process. We further hypothesize that the protective effects of indole-TEMPO conjugates partially reside in maintaining optimal mitochondrial function.

He krien-β- [...] multifunctional particle with two cholinesterase inhibitors

The invention relates to the field of medicinal chemistry, and particularly relates to tacrine-beta-carboline conjoined compounds (I, II and III). The pharmacodynamic test proves that the compound disclosed by the invention can be used as a multifunction cholinesterase inhibitor, and can be clinically applied to treatment of an alzheimer disease.

AUTOTAXIN INHIBITORS AND USES THEREOF

Described herein are methods and compositions for the treatment of conditions, diseases, or disorders associated with autotaxin activity. The methods and compositions disclosed herein include the use of at least one autotaxin inhibitor compound.

Methods for the treatment of metabolic disorders by a selective small molecule autotaxin inhibitor

Described herein are methods and compositions for treatment or prevention of metabolic disorder(s) in an individual. The methods and compositions disclosed herein include the use of at least one autotaxin inhibitor compound.

TETRACYCLIC AUTOTAXIN INHIBITORS

Described herein are compounds that are autotaxin inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with autotaxin activity.

T3P-Promoted, Mild, One-Pot Syntheses of Constrained Polycyclic Lactam Dipeptide Analogues via Stereoselective Pictet-Spengler and Meyers Lactamization Reactions

A new convenient, mild, one-pot procedure is described for the diastereoselective synthesis of constrained 7,5- and 7,6-fused azabicycloalkanes. Using 2-formyl-L-tryptophan and 2-formyl-l-phenylalanine as bielectrophilic building blocks, T3P-mediated Pict

Copper(II)-containing C2-symmetric bistetracarboline amides in enantioselective Henry reactions

A series of new C2-symmetric chiral diamides were synthesized from l-tryptophan and used as chiral ligands chelated with Cu(II) in enantioselective Henry reactions. Ligand 4a with CuCl2·2H2O (5%) showed effective catalytic